News Column

Advanced Cell Technology Names Paul Wotton as President and CEO

June 27, 2014

Advanced Cell Technology reported the appointment of Paul Wotton, Ph.D., to the position of President and Chief Executive Officer.

According to a release from the company, Dr. Wotton is a veteran of the biopharmaceutical industry and has a track record of leading companies to clinical, financial and commercial success. Dr. Wotton joins ACT from Antares Pharma Inc., where he served as President and CEO since October, 2008.

"We are very pleased to attract an executive of Paul's caliber. His experience in leading Antares from a biopharmaceutical company in early-stage clinical development to a commercial enterprise approaching profitability should prove invaluable as ACT moves its scientific platform through the clinic and focuses on commercial and partnership opportunities," said Michael Heffernan, Chairman of the Board of Directors of ACT. "With the vast majority of the legacy issues now behind the company, Paul is joining at an exciting time as we move our RPE program for the treatment of SMD/AMD into Phase 2 development. I would also like to thank the management team, led by Interim President Ted Myles, for their excellent leadership through this transition period."

"I am delighted to join ACT at this pivotal time in its growth. The company is now ready to pursue its Phase II clinical trials for AMD and SMD, Phase I for MMD and to advance the novel programs in its pre-clinical pipeline," commented Dr. Wotton. "Cell based therapies are an exciting opportunity and ACT is at the forefront of these developments. I believe we have an incredible opportunity to bring these novel therapies to patients in need and I am very pleased to be part of this initiative."

Advanced Cell Technology is a Marlborough, Mass.-based biotechnology company.

More Information:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Manufacturing Close - Up

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters